Brought to you by 
Amsterdam Molecular Therapeutics grosses €55.7mm in IPO
23 Jul 2007
Executive Summary
Gene drug developer Amsterdam Molecular Therapeutics BV has grossed €55.7mm ($72.4mm) in its initial public offering on Euronext Amsterdam's Eurolist. It sold 5.5mm new ordinary shares (including a partial exercise of the overallotment) at €10 each. Earlier this month the company planned to offer the shares at €8-10 apiece.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amsterdam Molecular Therapeutics grosses €55.7mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice